Increased vimentin mRNA expression in MCF-7 breast cancer cell line after repeated endoxifen-treatment
Background: Epithelial mesenchymal transition (EMT) plays a significant role in the development of cancer cell resistance to drugs. Vimentin, a type III intermediate filament protein, is a marker of EMT. Vimentin's over-expression in cancer correlates well with increased tumor growth, change i...
Main Authors: | Paramita Paramita, Melva Louisa, Nafrialdi Nafrialdi |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine Universitas Indonesia
2017-01-01
|
Series: | Medical Journal of Indonesia |
Subjects: | |
Online Access: | http://mji.ui.ac.id/journal/index.php/mji/article/view/1397 |
Similar Items
-
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
by: Paul Chen, et al.
Published: (2018-01-01) -
Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia
by: Sharon Wu, et al.
Published: (2018-06-01) -
Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): A systematic analysis
by: Ying Hui, et al.
Published: (2015-07-01) -
Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer
by: Thomas Helland, et al.
Published: (2021-03-01) -
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
by: Clara Inkyung Lee, et al.
Published: (2020-12-01)